about
Warburg Effect - a Consequence or the Cause of Carcinogenesis?Validation of functional imaging as a biomarker for radiation treatment responseIs carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?Radioluminescence microscopy: measuring the heterogeneous uptake of radiotracers in single living cellsA systems approach for tumor pharmacokineticsCo-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.Intratumoral Heterogeneous F-18 Fluorodeoxyglucose Uptake Corresponds with Glucose Transporter-1 and Ki-67 Expression in a Case of Krukenberg Tumor: Localization of Intratumoral Hypermetabolic Focus by Fused PET/MR ImageRadiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?Correlation of intra-tumor 18F-FDG uptake heterogeneity indices with perfusion CT derived parameters in colorectal cancer.18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT(18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application.Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.Broadening the scope of image-guided radiotherapy (IGRT).The influence of tumor oxygenation on (18)F-FDG (fluorine-18 deoxyglucose) uptake: a mouse study using positron emission tomography (PET)Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome.Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studiesCharacterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.Tumour microenvironment heterogeneity affects the perceived spatial concordance between the intratumoural patterns of cell proliferation and 18F-fluorothymidine uptakeRevisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials.Intratumoral Heterogeneity of Subcutaneous Nodules in a Never-Smoker Woman of Lung Squamous Cell Carcinoma Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography: A Case Report.Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.Targeted molecular imaging in oncology: focus on radiation therapy.The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.The prognostic value of PET and PET/CT in cervical cancerAn alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of conceptExpression and clinical significance of glucose transporter-1 in pancreatic cancer.[F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland.Hypoxia in microscopic tumors.FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo.Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.FDG PET in Prostate Cancer.Molecular imaging of hypoxia with radiolabelled agentsCombined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer.PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.Individualization of cancer treatment from radiotherapy perspective.
P2860
Q26751015-9C111CD1-D111-4BD6-B4FD-2F5249360814Q26823165-30F77D08-54E9-46D4-99C9-56998E44FD20Q26849504-F4D44F51-895F-4CC8-8A39-A3FEB5B826F2Q27316441-F6EE6D3E-A5F8-4570-926F-F68189952F25Q28477077-7AC8383C-A942-4AF7-93AE-F29BE97984B9Q33515391-2EE42FBF-3A6E-4A01-A8A2-94AAD56419EEQ33547295-56EA16BC-1333-4233-BC05-82EEF153CECCQ33550577-ECD70716-0B3F-4900-9CA1-86BF1FDB5C96Q33704453-A22826B2-9939-4013-82C7-4FA274A9E61FQ33723814-936FF8DB-05CF-4080-B433-14D88028B1DDQ33753620-7CF84E61-9284-4511-9047-36065AEFD083Q33798433-3166ADF2-4DCC-4596-987A-6AF07969CB3BQ33798559-4CE248DE-6B7B-4D71-B6AC-57B3B5F1CF73Q33912335-485CF8BC-D745-4258-966E-28E41EE42D98Q33936624-2F2CF98D-F661-46C2-BFAC-6E78E15286B2Q33943514-B1911D17-E0DC-47AA-8423-BCD92AA3DDB9Q34538538-15471143-52F3-4E7C-A44B-6D29C5F25A38Q35089180-D4A275E8-5F1F-42DE-A1A8-2C785FB2F1DDQ35151263-E9E330D2-9CA0-4E99-A9A3-56070D1F2BFAQ35216099-D7527253-1E85-4D35-816F-A48BA12985C8Q36070106-5E13CC0C-85CB-4F89-8DC5-03B2E3A0FF1FQ36088862-9F635002-ECDE-4599-BDC9-3793A807EDB9Q36193991-A1F82287-0AD1-4278-B920-E56220BFE470Q36475108-9CB57ABA-F8BD-4C37-B92F-B7A0E36A1FFBQ36528175-C19CD7B0-6B97-49D7-BD5F-9A92704529A3Q36550616-B61AAC54-37FB-44C0-80C8-08B3001554C0Q36763115-2C77D199-0707-4456-A1FC-C993215BB7EDQ36836254-F282E958-4E3E-447C-853F-A37C896A9FBBQ36885338-EB5FB7DC-AA65-4B45-ADE2-BE75F386CFC9Q37001207-B2476D38-9EE4-4635-99C0-85AEB726B296Q37085677-8B9F7418-23CF-493E-8B28-780B928DBD7EQ37126963-3B6544D6-4E99-488C-B68E-ABE7C8D60391Q37225698-6D96AD58-8B3E-40B8-8838-B4254858D38AQ37325974-5F1B6E51-45CE-437A-B15A-0264CB2EDC31Q37352995-41FEA339-5344-4A56-AE9E-EAE94F92AC8BQ37378239-603504C2-2BCF-44E9-8FA6-41DEE271AF18Q37474422-45B067B6-4E9D-4A7B-AE6B-842F87A188C1Q37627007-5D1CFAC4-1A31-407F-943C-B4B4FEDAAD01Q37832131-A72E8744-5B4A-4F7A-B8FA-76899D9338CBQ37989616-44DF29F3-0B86-4AA3-A108-07D521214CEC
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Dependence of FDG uptake on tumor microenvironment.
@ast
Dependence of FDG uptake on tumor microenvironment.
@en
type
label
Dependence of FDG uptake on tumor microenvironment.
@ast
Dependence of FDG uptake on tumor microenvironment.
@en
prefLabel
Dependence of FDG uptake on tumor microenvironment.
@ast
Dependence of FDG uptake on tumor microenvironment.
@en
P2093
P1476
Dependence of FDG uptake on tumor microenvironment
@en
P2093
Andrei Pugachev
C Clifton Ling
John L Humm
Jose Campa
Shutian Ruan
Steven M Larson
P304
P356
10.1016/J.IJROBP.2005.02.009
P407
P50
P577
2005-06-01T00:00:00Z